AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 24898858 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 311
Study 23422056 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based Voluntary Counselling and Testing
Number of subjects: 1500
Study 23422056 — intervention group
Group type: COMPARATOR
Intervention: Other testing approaches
Number of subjects: 1500
Study 23422056 — intervention group
Group type: EXPERIMENTAL
Intervention: Being tested for HIV
Number of subjects: 1500
Study 23422056 — intervention group
Group type: COMPARATOR
Intervention: Home-based Voluntary Counselling and Testing vs. Other testing approaches
Number of subjects: 1500
Study 20937107 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular fluid levels of progesterone
Number of subjects: 35
Study 20937107 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular fluid levels of testosterone
Number of subjects: 35
Study 20937107 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular fluid levels of estradiol
Number of subjects: 35
Study 20937107 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulosa cell production of progesterone
Number of subjects: 35
Study 20937107 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulosa cell production of estradiol
Number of subjects: 35
Study 20937107 — intervention group
Group type: EXPERIMENTAL
Intervention: Granulosa cell production of testosterone
Number of subjects: 35
Study 20937107 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of follicular estradiol levels with progesterone levels
Number of subjects: 35
Study 20937107 — intervention group
Group type: EXPERIMENTAL
Intervention: Correlation of follicular estradiol levels with testosterone levels
Number of subjects: 35
Study 18706103 — intervention group
Group type: EXPERIMENTAL
Intervention: Water-based training program with perturbation exercises (24 sessions over 12 weeks)
Number of subjects: 36
Study 18706103 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 36
Study 16624551 — intervention group
Group type: EXPERIMENTAL
Intervention: Radical mastectomy
Number of subjects: 0
Study 16624551 — intervention group
Group type: COMPARATOR
Intervention: Conservative quadrantectomy
Number of subjects: 0
Study 12660665 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiologic pacing (dual-chamber or atrial only)
Number of subjects: 1990
Study 12660665 — intervention group
Group type: COMPARATOR
Intervention: Ventricular pacing
Number of subjects: 1990
Study 11078174 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortisol (oral administration for 2 or 5 days)
Number of subjects: 14
Study 11078174 — intervention group
Group type: COMPARATOR
Intervention: Placebo (oral administration for 2 or 5 days)
Number of subjects: 14
Study 8740998 — intervention group
Group type: EXPERIMENTAL
Intervention: Tacrine hydrochloride (Cognex)
Number of subjects: 1100
Study 8740998 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1100
Study 1400058 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms of intranasal DDAVP
Number of subjects: 13
Study 1400058 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study 3839390 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.5% timolol
Number of subjects: 32
Study 3839390 — intervention group
Group type: EXPERIMENTAL
Intervention: 2% pilocarpine
Number of subjects: 32
Study 3839390 — intervention group
Group type: COMPARATOR
Intervention: Normal saline
Number of subjects: 32
Study 30716525 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT) with a brain target volume receiving focal radiation therapy in fractions of 1.8 Gy to a total of 50.4 Gy
Number of subjects: 195
Study 30716525 — intervention group
Group type: EXPERIMENTAL
Intervention: Radiation therapy (RT)
Number of subjects: 195
Study 30716525 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor progression
Number of subjects: 195
Study 29341463 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed teaching methods with a high percentage of non-phonically decodable vocabulary
Number of subjects: 12
Study 29341463 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed teaching methods with low percentage of non-decodable vocabulary
Number of subjects: 12
Study 29341463 — intervention group
Group type: COMPARATOR
Intervention: Synthetic phonics only and phonically decodable vocabulary (Control)
Number of subjects: 12
Study 26395351 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily tooth brushing with 500 ppm fluoride toothpaste, supervised by specially trained dental nurses.
Number of subjects: 2112
Study 26395351 — intervention group
Group type: COMPARATOR
Intervention: Tooth brushing instructions three to four times a year (Control group).
Number of subjects: 2112
Study 26395351 — intervention group
Group type: COMPARATOR
Intervention: Control group (tooth brushing instructions).
Number of subjects: 2112
Study 24210789 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (50,000U) each week for 8 weeks plus 200mg calcium and a multivitamin (containing vitamin D3 400U)
Number of subjects: 130
Study 24210789 — intervention group
Group type: COMPARATOR
Intervention: 200mg calcium plus a multivitamin (containing vitamin D3 400U)
Number of subjects: 130
Study 22538327 — intervention group
Group type: EXPERIMENTAL
Intervention: Prostacyclin treatment
Number of subjects: 48
Study 22538327 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 48
Study 22538327 — intervention group
Group type: EXPERIMENTAL
Intervention: CT(i) Rotterdam classification
Number of subjects: 48
Study 22538327 — intervention group
Group type: EXPERIMENTAL
Intervention: Marshall, Rotterdam, Morris‐Marshall classifications
Number of subjects: 48
Study 20449689 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAP38
Number of subjects: 0
Study 20449689 — intervention group
Group type: EXPERIMENTAL
Intervention: PACAP
Number of subjects: 0
Study 20449689 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX)
Number of subjects: 0
Study 17518878 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial Trial Intervention protocol
Number of subjects: 8
Study 16130055 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen (1 g every sixth hour)
Number of subjects: 80
Study 16130055 — intervention group
Group type: COMPARATOR
Intervention: Oral acetaminophen (1 g every sixth hour)
Number of subjects: 80
Study 16130055 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 12404086 — intervention group
Group type: EXPERIMENTAL
Intervention: Acute tryptophan depletion (ATD) via oral mixture of amino acids
Number of subjects: 10
Study 12404086 — intervention group
Group type: COMPARATOR
Intervention: Control mixture of amino acids
Number of subjects: 10
Study 9701735 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrovaporization of the prostate (TVP)
Number of subjects: 20
Study 9701735 — intervention group
Group type: COMPARATOR
Intervention: Laser ablation of the prostate (LAP)
Number of subjects: 20
Study 8539546 — intervention group
Group type: EXPERIMENTAL
Intervention: Cefpodoxime proxetil
Number of subjects: 286
Study 8539546 — intervention group
Group type: COMPARATOR
Intervention: Amoxicillin
Number of subjects: 286
Study 2393625 — intervention group
Group type: EXPERIMENTAL
Intervention: Skills training and peer support intervention
Number of subjects: 0
Study 2393625 — intervention group
Group type: COMPARATOR
Intervention: Lecture/discussion only
Number of subjects: 0
Study 698028 — intervention group
Group type: EXPERIMENTAL
Intervention: Iotroxamide
Number of subjects: 0
Study 31606734 — intervention group
Group type: EXPERIMENTAL
Intervention: Integrase strand transfer inhibitors (ISTIs)
Number of subjects: 5000
Study 31606734 — intervention group
Group type: EXPERIMENTAL
Intervention: Dolutegravir and Bictegravir
Number of subjects: 5000
Study 31606734 — intervention group
Group type: EXPERIMENTAL
Intervention: Rilpivirine (NNRTI)
Number of subjects: 5000
Study 31606734 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir alafenamide (NRTI)
Number of subjects: 5000
Study 30712404 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of IM olanzapine
Number of subjects: 63
Study 30712404 — intervention group
Group type: COMPARATOR
Intervention: 0.3 mg of oral clonidine
Number of subjects: 63
Study 25600568 — intervention group
Group type: EXPERIMENTAL
Intervention: Bevacizumab with second-line chemotherapy (mFOLFOX-6 or FOLFIRI)
Number of subjects: 185
Study 25600568 — intervention group
Group type: COMPARATOR
Intervention: Chemotherapy alone (mFOLFOX-6 or FOLFIRI without bevacizumab)
Number of subjects: 185
Study 23831423 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS treatment for 3 weeks (1 hour per day) on the median nerve region of the most impaired hand
Number of subjects: 0
Study 23831423 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation for 3 weeks (1 hour per day) on the median nerve region of the most impaired hand
Number of subjects: 0
Study 21966856 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole, 2.5 mg, oral route for 36 months
Number of subjects: 40
Study 21966856 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen, 20 mg, oral route for 36 months
Number of subjects: 40
Study 21966856 — intervention group
Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 40
Study 21966856 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen
Number of subjects: 40
Study 19948980 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia (glucose > or =140 mg/dL) on admission
Number of subjects: 30536
Study 19948980 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperglycemia (glucose > or =140 mg/dL) after admission
Number of subjects: 30536
Study 19948980 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (glucose < or =70 mg/dL) on admission
Number of subjects: 30536
Study 19948980 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia (glucose < or =70 mg/dL) postadmission
Number of subjects: 30536
Study 19948980 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoglycemia redefined as glucose < or =60 mg/dL
Number of subjects: 30536
Study 19948980 — intervention group
Group type: EXPERIMENTAL
Intervention: Postadmission hypoglycemia in insulin-treated patients
Number of subjects: 30536
Study 16618375 — intervention group
Group type: EXPERIMENTAL
Intervention: Music therapy
Number of subjects: 38
Study 16618375 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 38
Study 15082018 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation training (listening to a 12 min relaxation tape)
Number of subjects: 32
Study 15082018 — intervention group
Group type: COMPARATOR
Intervention: Control group (pressing a button whenever a body part was mentioned)
Number of subjects: 32
Study 11103165 — intervention group
Group type: EXPERIMENTAL
Intervention: LMW heparin delivered by J-Tip
Number of subjects: 60
Study 11103165 — intervention group
Group type: COMPARATOR
Intervention: LMW heparin delivered by standard needle and syringe
Number of subjects: 60
Study 9057938 — intervention group
Group type: EXPERIMENTAL
Intervention: Scrub with an inert scrub brush and 4% chlorhexidine soap with isopropyl alcohol
Number of subjects: 15
Study 9057938 — intervention group
Group type: COMPARATOR
Intervention: Wash with 4% chlorhexidine soap with isopropyl alcohol alone
Number of subjects: 15
Study 8448733 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate statistics
Number of subjects: 0
Study 8448733 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study 3746543 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIgG (12 gm in 12 hours or 24 gm on each of 5 consecutive days)
Number of subjects: 51
Study 3746543 — intervention group
Group type: COMPARATOR
Intervention: Antibiotics alone (control group)
Number of subjects: 51
Study 3746543 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIgG (both low and high doses)
Number of subjects: 51
Study 2453995 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine/prilocaine cream (EMLA) applied topically, 10 g one hour before operation
Number of subjects: 55
Study 2453995 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 55
Study 31770084 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-sorb® cream
Number of subjects: 26
Study 31770084 — intervention group
Group type: COMPARATOR
Intervention: Control (no cream)
Number of subjects: 26
Study 30993323 — intervention group
Group type: EXPERIMENTAL
Intervention: Daidzein and Chinese herbs mixture (0.02%)
Number of subjects: 240
Study 30993323 — intervention group
Group type: COMPARATOR
Intervention: Control (basal diet)
Number of subjects: 240
Study 27783363 — intervention group
Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 118
Study 25738667 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis E vaccine
Number of subjects: 56302
Study 25738667 — intervention group
Group type: COMPARATOR
Intervention: Hepatitis B vaccine (control)
Number of subjects: 56302
Study 24095985 — intervention group
Group type: EXPERIMENTAL
Intervention: Erythritol candies
Number of subjects: 0
Study 24095985 — intervention group
Group type: COMPARATOR
Intervention: Xylitol candies
Number of subjects: 0
Study 24095985 — intervention group
Group type: COMPARATOR
Intervention: Sorbitol candies
Number of subjects: 0
Study 21255869 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonablative 1550-nm fractional laser therapy
Number of subjects: 20
Study 21255869 — intervention group
Group type: COMPARATOR
Intervention: Triple topical therapy (hydroquinone 5%, tretinoin 0.05%, and triamcinolone acetonide 0.1% cream)
Number of subjects: 20
Study 18992209 — intervention group
Group type: EXPERIMENTAL
Intervention: Amodiaquine
Number of subjects: 328
Study 18992209 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate
Number of subjects: 328
Study 18992209 — intervention group
Group type: EXPERIMENTAL
Intervention: Artesunate-amodiaquine
Number of subjects: 328
Study 18992209 — intervention group
Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 328
Study 16550669 — intervention group
Group type: EXPERIMENTAL
Intervention: Active manuka honey dressing
Number of subjects: 100
Study 16550669 — intervention group
Group type: COMPARATOR
Intervention: Paraffin-impregnated tulle gras
Number of subjects: 100
Study 12837218 — intervention group
Group type: EXPERIMENTAL
Intervention: lamivudine treatment
Number of subjects: 20
Study 12837218 — intervention group
Group type: COMPARATOR
Intervention: control group (10 patients)
Number of subjects: 20
Study 10848682 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nitric oxide (INO) at 4 parts per million
Number of subjects: 11
Study 10848682 — intervention group
Group type: EXPERIMENTAL
Intervention: Positive end-expiratory pressure (PEEP) at 10 cm H2O
Number of subjects: 11
Study 10848682 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of INO and PEEP at 10 cm H2O
Number of subjects: 11
Study 9100140 — intervention group
Group type: EXPERIMENTAL
Intervention: Teamwork program between physicians and pharmacists
Number of subjects: 94
Study 9100140 — intervention group
Group type: COMPARATOR
Intervention: Standard medical care (Control)
Number of subjects: 94
Study 7951597 — intervention group
Group type: EXPERIMENTAL
Intervention: GnRH agonists
Number of subjects: 0
Study 3543069 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenfluramine
Number of subjects: 12
Study 3543069 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study 30096148 — intervention group
Group type: EXPERIMENTAL
Intervention: Midwife or physician for PAC including contraceptive counselling
Number of subjects: 810
Study 27017088 — intervention group
Group type: EXPERIMENTAL
Intervention: High nonverbal involvement
Number of subjects: 318
Study 27017088 — intervention group
Group type: EXPERIMENTAL
Intervention: Low nonverbal involvement
Number of subjects: 318
Study 27017088 — intervention group
Group type: EXPERIMENTAL
Intervention: Written disclosure vignette without nonverbal information
Number of subjects: 318
Study 26586327 — intervention group
Group type: COMPARATOR
Intervention: GLP-1 receptor agonist exenatide (acute intervention)
Number of subjects: 60
Study 26586327 — intervention group
Group type: COMPARATOR
Intervention: GLP-1 receptor agonist liraglutide (12-week intervention)
Number of subjects: 60
Study 26586327 — intervention group
Group type: COMPARATOR
Intervention: DPP-4 inhibitor sitagliptin (12-week intervention)
Number of subjects: 60
Study 23896631 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoradiation (45.0 Gy and boost up to 54.0 Gy plus concurrent and subsequent gemcitabine)
Number of subjects: 100
Study 20043816 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-742457 35 mg
Number of subjects: 371
Study 20043816 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-742457 5 mg
Number of subjects: 371
Study 20043816 — intervention group
Group type: EXPERIMENTAL
Intervention: SB-742457 15 mg
Number of subjects: 371
Study 20043816 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 371
Study 17804302 — intervention group
Group type: EXPERIMENTAL
Intervention: School-based supervised asthma therapy
Number of subjects: 295
Study 17804302 — intervention group
Group type: COMPARATOR
Intervention: Parent supervised asthma therapy
Number of subjects: 295
Study 16644288 — intervention group
Group type: EXPERIMENTAL
Intervention: rhIL‐11
Number of subjects: 40
Study 16644288 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 12699019 — intervention group
Group type: EXPERIMENTAL
Intervention: C (Caffeine)
Number of subjects: 43
Study 12699019 — intervention group
Group type: COMPARATOR
Intervention: P (Placebo)
Number of subjects: 43
Study 10192233 — intervention group
Group type: EXPERIMENTAL
Intervention: Amlodipine (2.5 to 10 mg/day)
Number of subjects: 46
Study 10192233 — intervention group
Group type: EXPERIMENTAL
Intervention: Enalapril (5 to 40 mg/day)
Number of subjects: 46
Study 7778075 — intervention group
Group type: EXPERIMENTAL
Intervention: C-reactive protein (CRP) testing
Number of subjects: 239
Study 7778075 — intervention group
Group type: COMPARATOR
Intervention: Control group (no CRP testing)
Number of subjects: 239
Study 1970027 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxapram infusion (2 mg per min for 6 h immediately after surgery and repeated on the first postoperative day)
Number of subjects: 39
Study 1970027 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 39
Study 1970027 — intervention group
Group type: EXPERIMENTAL
Intervention: Doxapram infusion
Number of subjects: 39
Study 6243527 — intervention group
Group type: EXPERIMENTAL
Intervention: 1,25-dihydroxycholecalciferol (1,25[OH]2D3)
Number of subjects: 18
Study 6243527 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 (D3)
Number of subjects: 18
Study 31733807 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung protection (PEEP 7 cm H2O and recruitment manoeuvres every 30 min)
Number of subjects: 45
Study 31733807 — intervention group
Group type: COMPARATOR
Intervention: Zero end-expiratory pressure (ZEEP; no recruitment manoeuvres)
Number of subjects: 45
Study 31733807 — intervention group
Group type: EXPERIMENTAL
Intervention: Lung protection (PEEP/RMs)
Number of subjects: 45
Study 31733807 — intervention group
Group type: COMPARATOR
Intervention: Zero end-expiratory pressure (ZEEP)
Number of subjects: 45
Study 30211667 — intervention group
Group type: EXPERIMENTAL
Intervention: Performance-based practice
Number of subjects: 0
Study 27849369 — intervention group
Group type: EXPERIMENTAL
Intervention: Assisted partner services (APS)
Number of subjects: 29
Study 24905260 — intervention group
Group type: EXPERIMENTAL
Intervention: Immediate loading (Columbus Bridge Protocol) with 4 to 6 implants, loaded within 24 hours
Number of subjects: 49
Study 24905260 — intervention group
Group type: COMPARATOR
Intervention: Delayed loading (two-stage surgical protocol) with 6 to 9 straight implants, loaded a mean of 8.75 months after surgery
Number of subjects: 49
Study 24905260 — intervention group
Group type: EXPERIMENTAL
Intervention: Both immediate and delayed loading groups
Number of subjects: 49
Study 23292055 — intervention group
Group type: EXPERIMENTAL
Intervention: Expectant management
Number of subjects: 25
Study 23292055 — intervention group
Group type: COMPARATOR
Intervention: Surgical management
Number of subjects: 25
Study 19371389 — intervention group
Group type: EXPERIMENTAL
Intervention: Varnish applied to the tissue conditioner (Group G1)
Number of subjects: 40
Study 19371389 — intervention group
Group type: COMPARATOR
Intervention: No treatment applied (Group G2)
Number of subjects: 40
Study 17911499 — intervention group
Group type: EXPERIMENTAL
Intervention: Perindopril (8 mg/d for 24 weeks)
Number of subjects: 17
Study 17911499 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study 16091984 — intervention group
Group type: EXPERIMENTAL
Intervention: New mattress technique
Number of subjects: 113
Study 16091984 — intervention group
Group type: COMPARATOR
Intervention: Cattell technique
Number of subjects: 113
Study 12163961 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery for colon cancer
Number of subjects: 1200
Study 12163961 — intervention group
Group type: COMPARATOR
Intervention: Open surgery for colon cancer
Number of subjects: 1200
Study 9727729 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg diazepam
Number of subjects: 44
Study 9727729 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg chlorazepate
Number of subjects: 44
Study 9727729 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg oxazepam
Number of subjects: 44
Study 9727729 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 44
Study 7991336 — intervention group
Group type: EXPERIMENTAL
Intervention: Covert orienting of attention
Number of subjects: 0
Study 7991336 — intervention group
Group type: EXPERIMENTAL
Intervention: Invalid cues
Number of subjects: 0
Study 7991336 — intervention group
Group type: EXPERIMENTAL
Intervention: High event rate
Number of subjects: 0
Study 2532841 — intervention group
Group type: EXPERIMENTAL
Intervention: etretin (50 mg/day)
Number of subjects: 30
Study 2532841 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study 2532841 — intervention group
Group type: EXPERIMENTAL
Intervention: etretin (during second period of 20 weeks)
Number of subjects: 30
Study 2532841 — intervention group
Group type: EXPERIMENTAL
Intervention: etretin
Number of subjects: 30
Study 29946649 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine combined with sevoflurane (D group)
Number of subjects: 120
Study 29946649 — intervention group
Group type: COMPARATOR
Intervention: Sevoflurane only (S group)
Number of subjects: 120